Skip to main content

Clozapine Use: Second Descriptive Analysis

    Basic Details
    Date Posted
    Status
    Complete
    Medical Product
    clozapine
    Description

    In this analysis, we examined the utilization of clozapine using seven different exposure definitions. We defined each exposure by varying the specified parameters of pre-index enrollment period, washout period, and treatment episode gap.

    The study period includes data from January 1, 2010 to September 30, 2019. We executed this request on Merative™ MarketScan® Research Databases on August 6, 2021.

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2010 – September 30, 2019
    Analysis Type
    Descriptive
    Population / Cohort
    All individuals
    Data Sources
    Merative™ MarketScan® Research Databases